Drug Trial Radar · NCT04591431
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Last checked: Nov 19, 2026Latest source record: Oct 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
400
Actual
Start
Oct 7, 2020
Primary completion
Dec 2024
Study completion Jun 2025
Sponsor
- Lead sponsor
- Fondazione per la Medicina PersonalizzataAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 19, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, prospective, multicenter, Proof of Concept, Phase II clinical trial Study. The main objective of the study is to evaluate the efficacy (meant as overall response rate ORR) of TT (targeted Therapy) vs SoC (standard of Care) in patients with progressive disease (recurrent and/or metastatic) of breast cancer, metastatic gastro-intestinal tumors, non small cell lung cancer (NSCLC) or others. Patients should have completed at least 1 line of treatment and no more than 2 as defined by the current version of the AIOM (Italian Association of Medical Oncology) guidelines. Patients are included if surgery is contraindicated.
Conditions
- Breast Cancer
- Gastrointestinal Cancer
- Non Small Cell Lung Cancer
- Other Cancer
Interventions
ErlotinibDrug
TT arm
TrastuzumabDrug
TT arm
Trastuzumab emtansineDrug
TT arm
PertuzumabDrug
TT arm
LapatinibDrug
TT arm
EverolimusDrug
TT arm
VemurafenibDrug
TT arm
CobimetinibDrug
TT arm
AlectinibDrug
TT arm
BrigatinibDrug
TT arm
PalbociclibDrug
TT arm
PonatinibDrug
TT arm
VismogedibDrug
TT arm
ItacitinibDrug
TT arm
IpatasertibDrug
TT arm
EntrectinibDrug
TT arm
AtezolizumabDrug
TT arm
NivolumabDrug
TT arm
IpilimumabDrug
TT arm
PemigatinibDrug
TT arm
Oncology DrugsDrug
Standard of Care Arm
PralsetinibDrug
TT arm
SelpercatinibDrug
TT arm
TalazoparibDrug
TT arm
TepotinibDrug
TT arm
AlpelisibDrug
TT arm
Primary outcomes
What the sponsor says the trial is designed to measure.
- OVERALL RESPONSE RATE (ORR)Time frame: 42 months
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
OSPEDALI RIUNITI di ANCONA
Ancona, Italy
Centro Riferimento Oncologico
Aviano, Italy
Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari
Bari, Italy
Asst Papa Giovanni Xxiii
Bergamo, Italy
Ospedale Bellaria
Bologna, Italy
Ospedale di Carpi
Carpi, Italy
Arnas Garibaldi- Nuovo Ospedale Garibaldi - Nesima
Catania, Italy
A.O. Mater Domini Catanzaro
Catanzaro, Italy
Azienda Ospedaliero-Universitaria Di Ferrara
Ferrara, Italy
E.O. Ospedali Galliera
Genova, Italy
Ospedale Policlinico San Martino
Genova, Italy
Ospedale Della Misericordia
Grosseto, Italy
I.R.S.T. Srl Irccs
Meldola, Italy
Ao Papardo
Messina, Italy
Istituto Europeo Di Oncologia
Milan, Italy
Istituto Nazionale Tumori Di Napoli Irccs Pascale
Naples, Italy
Ospedale Classificato Sacro Cuore - Don Calabria
Negrar, Italy
I.R.C.C.S. Istituto Oncologico Veneto
Padova, Italy
Az.Osp.Univ.P.Giaccone
Palermo, Italy
Azienda Ospedaliera Di Perugia
Perugia, Italy
Casa Di Cura Privata Osp. P. Pederzoli
Peschiera del Garda, Italy
Azienda Usl Di Piacenza
Piacenza, Italy
Azienda Ospedaliero-Universitaria Pisana
Pisa, Italy
Nuovo Ospedale Di Prato - S. Stefano
Prato, Italy
Ospedale "Santa Maria Delle Croci"
Ravenna, Italy
Arcispedale Santa Maria Nuova Di Reggio Emilia
Reggio Emilia, Italy
Az. Osp. Uni. Policlinico Umberto I
Roma, Italy
Azienda Ospedaliera Sant'Andrea
Roma, Italy
Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
Roma, Italy
Ospedale Fatebenefratelli
Roma, Italy
Policl. Univ. Campus Bio Medico
Roma, Italy
Casa Sollievo della Sofferenza - Opera Padre Pio
San Giovanni Rotondo, Italy
Azienda Ospedaliera 'S. Maria' - Terni
Terni, Italy
AO Ordine Mauriziano
Torino, Italy
Humanitas Gradenigo
Torino, Italy
IRCCS Candiolo
Torino, Italy
Complesso Ospedaliero Di Belcolle- Ospedale Di Belcolle
Viterbo, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.